Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia

Here, we report a female patient developing neuroleptic malignant syndrome following the use of a combination of clozapine and haloperidol. Subsequently, the patient presented withdrawal effects after an abrupt discontinuation of clozapine. Psychiatrists not aware of possible clozapine-withdrawal ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Minfeng, Gu, Huaying, Zheng, Liangrong, Wang, Houliang, Zhong, Zhiyong, Wen, Shenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820214/
https://www.ncbi.nlm.nih.gov/pubmed/27099499
http://dx.doi.org/10.2147/NDT.S103687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820214/
https://www.ncbi.nlm.nih.gov/pubmed/27099499
http://dx.doi.org/10.2147/NDT.S103687

Ejemplares similares